Literature DB >> 8381158

The inability to process a self-peptide allows autoreactive T cells to escape tolerance.

M J Mamula1.   

Abstract

It is now clear that antigen presenting cells (APCs) do not present all the possible peptides of self-proteins to the immune system. When then, is the fate of T cells specific for those self-peptides that escape processing? In this study, the COOH-terminal peptide (residues 81-104) of self cytochrome c (cyt c) elicited strong autoimmune T cells, as well as autoantibodies specific for this immunogen. These T cells did not respond to stimulation with the whole self cyt c molecule, demonstrating that APCs cannot process and present the self 81-104 peptide. Whereas mice were unresponsive to immunization with the whole mouse cyt c molecule, the mouse 81-104 fragment together with the whole self-molecule induced and amplified the autoimmune T cell response to sites within the 1-80 peptide. T cells that never contact the relevant self-peptide are functionally ignorant. They do not become tolerized or deleted, nor do they normally participate in immune responses to the native whole self-protein, since APCs cannot present the 81-104 peptide.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8381158      PMCID: PMC2190887          DOI: 10.1084/jem.177.2.567

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  9 in total

Review 1.  Why peptides? Their possible role in the evolution of MHC-restricted T-cell recognition.

Authors:  Z A Nagy; P V Lehmann; F Falcioni; S Muller; L Adorini
Journal:  Immunol Today       Date:  1989-04

Review 2.  Acquisition of immunologic self-tolerance.

Authors:  R H Schwartz
Journal:  Cell       Date:  1989-06-30       Impact factor: 41.582

3.  Limit of T cell tolerance to self proteins by peptide presentation.

Authors:  H Schild; O Rötzschke; H Kalbacher; H G Rammensee
Journal:  Science       Date:  1990-03-30       Impact factor: 47.728

4.  Cleavage of cytochrome c with cyanogen bromide.

Authors:  G Corradin; H A Harbury
Journal:  Biochim Biophys Acta       Date:  1970-12-22

5.  T cell tolerance by clonal elimination in the thymus.

Authors:  J W Kappler; N Roehm; P Marrack
Journal:  Cell       Date:  1987-04-24       Impact factor: 41.582

6.  The specificity of human anti-cytochrome c autoantibodies that arise in autoimmune disease.

Authors:  M J Mamula; R Jemmerson; J A Hardin
Journal:  J Immunol       Date:  1990-03-01       Impact factor: 5.422

7.  Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen.

Authors:  P V Lehmann; T Forsthuber; A Miller; E E Sercarz
Journal:  Nature       Date:  1992-07-09       Impact factor: 49.962

8.  Breaking T cell tolerance with foreign and self co-immunogens. A study of autoimmune B and T cell epitopes of cytochrome c.

Authors:  M J Mamula; R H Lin; C A Janeway; J A Hardin
Journal:  J Immunol       Date:  1992-08-01       Impact factor: 5.422

9.  Induction of autoreactive B cells allows priming of autoreactive T cells.

Authors:  R H Lin; M J Mamula; J A Hardin; C A Janeway
Journal:  J Exp Med       Date:  1991-06-01       Impact factor: 14.307

  9 in total
  39 in total

1.  Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity.

Authors:  L Casciola-Rosen; F Andrade; D Ulanet; W B Wong; A Rosen
Journal:  J Exp Med       Date:  1999-09-20       Impact factor: 14.307

Review 2.  Antigen-specific immunotherapy for autoimmune disease: fighting fire with fire?

Authors:  M Peakman; C M Dayan
Journal:  Immunology       Date:  2001-12       Impact factor: 7.397

3.  Hierarchy of Epstein-Barr virus-specific cytotoxic T-cell responses in individuals carrying different subtypes of an HLA allele: implications for epitope-based antiviral vaccines.

Authors:  R Khanna; S R Burrows; A Neisig; J Neefjes; D J Moss; S L Silins
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

Review 4.  Oxidative Modifications in Tissue Pathology and Autoimmune Disease.

Authors:  Mei-Ling Yang; Hester A Doyle; Steven G Clarke; Kevan C Herold; Mark J Mamula
Journal:  Antioxid Redox Signal       Date:  2017-12-11       Impact factor: 8.401

Review 5.  Improving T cell responses to modified peptides in tumor vaccines.

Authors:  Jonathan D Buhrman; Jill E Slansky
Journal:  Immunol Res       Date:  2013-03       Impact factor: 2.829

6.  Cloning and characterization of the genes encoding the murine homologues of the human melanoma antigens MART1 and gp100.

Authors:  Y Zhai; J C Yang; P Spiess; M I Nishimura; W W Overwijk; B Roberts; N P Restifo; S A Rosenberg
Journal:  J Immunother       Date:  1997-01       Impact factor: 4.456

Review 7.  Autoantigens as Partners in Initiation and Propagation of Autoimmune Rheumatic Diseases.

Authors:  Antony Rosen; Livia Casciola-Rosen
Journal:  Annu Rev Immunol       Date:  2016-02-22       Impact factor: 28.527

8.  Unique conformation of cancer autoantigen B23 in hepatoma: a mechanism for specificity in the autoimmune response.

Authors:  Danielle B Ulanet; Michael Torbenson; Chi V Dang; Livia Casciola-Rosen; Antony Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-30       Impact factor: 11.205

9.  Collagen-induced arthritis in B10.RIII mice (H-2r): identification of an arthritogenic T-cell determinant.

Authors:  L K Myers; H Miyahara; K Terato; J M Seyer; J M Stuart; A H Kang
Journal:  Immunology       Date:  1995-04       Impact factor: 7.397

10.  T cell proliferative response induced by DNA topoisomerase I in patients with systemic sclerosis and healthy donors.

Authors:  M Kuwana; T A Medsger; T M Wright
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.